179 related articles for article (PubMed ID: 28714957)
1. IL-11 contribution to tumorigenesis in an NRF2 addiction cancer model.
Kitamura H; Onodera Y; Murakami S; Suzuki T; Motohashi H
Oncogene; 2017 Nov; 36(45):6315-6324. PubMed ID: 28714957
[TBL] [Abstract][Full Text] [Related]
2. NRF2 addiction in cancer cells.
Kitamura H; Motohashi H
Cancer Sci; 2018 Apr; 109(4):900-911. PubMed ID: 29450944
[TBL] [Abstract][Full Text] [Related]
3. A clinical drug library screen identifies clobetasol propionate as an NRF2 inhibitor with potential therapeutic efficacy in KEAP1 mutant lung cancer.
Choi EJ; Jung BJ; Lee SH; Yoo HS; Shin EA; Ko HJ; Chang S; Kim SY; Jeon SM
Oncogene; 2017 Sep; 36(37):5285-5295. PubMed ID: 28504720
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic transformation of mesenchymal stem cells decreases Nrf2 expression favoring in vivo tumor growth and poorer survival.
Funes JM; Henderson S; Kaufman R; Flanagan JM; Robson M; Pedley B; Moncada S; Boshoff C
Mol Cancer; 2014 Feb; 13():20. PubMed ID: 24491031
[TBL] [Abstract][Full Text] [Related]
5. Roles of Keap1-Nrf2 system in upper aerodigestive tract carcinogenesis.
Ohkoshi A; Suzuki T; Ono M; Kobayashi T; Yamamoto M
Cancer Prev Res (Phila); 2013 Feb; 6(2):149-59. PubMed ID: 23250896
[TBL] [Abstract][Full Text] [Related]
6. NRF2 Intensifies Host Defense Systems to Prevent Lung Carcinogenesis, but After Tumor Initiation Accelerates Malignant Cell Growth.
Satoh H; Moriguchi T; Saigusa D; Baird L; Yu L; Rokutan H; Igarashi K; Ebina M; Shibata T; Yamamoto M
Cancer Res; 2016 May; 76(10):3088-96. PubMed ID: 27020858
[TBL] [Abstract][Full Text] [Related]
7. FoxO3 inactivation promotes human cholangiocarcinoma tumorigenesis and chemoresistance through Keap1-Nrf2 signaling.
Guan L; Zhang L; Gong Z; Hou X; Xu Y; Feng X; Wang H; You H
Hepatology; 2016 Jun; 63(6):1914-27. PubMed ID: 26857210
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-33/ST2 axis promotes epithelial cell transformation and breast tumorigenesis via upregulation of COT activity.
Kim JY; Lim SC; Kim G; Yun HJ; Ahn SG; Choi HS
Oncogene; 2015 Sep; 34(38):4928-38. PubMed ID: 25531326
[TBL] [Abstract][Full Text] [Related]
9. Global downstream pathway analysis reveals a dependence of oncogenic NF-E2-related factor 2 mutation on the mTOR growth signaling pathway.
Shibata T; Saito S; Kokubu A; Suzuki T; Yamamoto M; Hirohashi S
Cancer Res; 2010 Nov; 70(22):9095-105. PubMed ID: 21062981
[TBL] [Abstract][Full Text] [Related]
10. Sequestosome 1/p62 facilitates HER2-induced mammary tumorigenesis through multiple signaling pathways.
Cai-McRae X; Zhong H; Karantza V
Oncogene; 2015 Jun; 34(23):2968-77. PubMed ID: 25088198
[TBL] [Abstract][Full Text] [Related]
11. Estrogen increases Nrf2 activity through activation of the PI3K pathway in MCF-7 breast cancer cells.
Wu J; Williams D; Walter GA; Thompson WE; Sidell N
Exp Cell Res; 2014 Nov; 328(2):351-60. PubMed ID: 25172557
[TBL] [Abstract][Full Text] [Related]
12. NRF2 promotes breast cancer cell proliferation and metastasis by increasing RhoA/ROCK pathway signal transduction.
Zhang C; Wang HJ; Bao QC; Wang L; Guo TK; Chen WL; Xu LL; Zhou HS; Bian JL; Yang YR; Sun HP; Xu XL; You QD
Oncotarget; 2016 Nov; 7(45):73593-73606. PubMed ID: 27713154
[TBL] [Abstract][Full Text] [Related]
13. Cancer Cell Growth Is Differentially Affected by Constitutive Activation of NRF2 by KEAP1 Deletion and Pharmacological Activation of NRF2 by the Synthetic Triterpenoid, RTA 405.
Probst BL; McCauley L; Trevino I; Wigley WC; Ferguson DA
PLoS One; 2015; 10(8):e0135257. PubMed ID: 26301506
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of NF-E2-related factor 2 inhibits the proliferation and growth of U251MG human glioma cells in a mouse xenograft model.
Ji XJ; Chen SH; Zhu L; Pan H; Zhou Y; Li W; You WC; Gao CC; Zhu JH; Jiang K; Wang HD
Oncol Rep; 2013 Jul; 30(1):157-64. PubMed ID: 23673813
[TBL] [Abstract][Full Text] [Related]
15. Activation of AKT pathway by Nrf2/PDGFA feedback loop contributes to HCC progression.
Liu D; Zhang Y; Wei Y; Liu G; Liu Y; Gao Q; Zou L; Zeng W; Zhang N
Oncotarget; 2016 Oct; 7(40):65389-65402. PubMed ID: 27588483
[TBL] [Abstract][Full Text] [Related]
16. Nrf2 prevents initiation but accelerates progression through the Kras signaling pathway during lung carcinogenesis.
Satoh H; Moriguchi T; Takai J; Ebina M; Yamamoto M
Cancer Res; 2013 Jul; 73(13):4158-68. PubMed ID: 23610445
[TBL] [Abstract][Full Text] [Related]
17. Autocrine/paracrine mechanism of interleukin-17B receptor promotes breast tumorigenesis through NF-κB-mediated antiapoptotic pathway.
Huang CK; Yang CY; Jeng YM; Chen CL; Wu HH; Chang YC; Ma C; Kuo WH; Chang KJ; Shew JY; Lee WH
Oncogene; 2014 Jun; 33(23):2968-77. PubMed ID: 23851503
[TBL] [Abstract][Full Text] [Related]
18. The nuclear matrix protein, NRP/B, enhances Nrf2-mediated oxidative stress responses in breast cancer cells.
Seng S; Avraham HK; Jiang S; Yang S; Sekine M; Kimelman N; Li H; Avraham S
Cancer Res; 2007 Sep; 67(18):8596-604. PubMed ID: 17875699
[TBL] [Abstract][Full Text] [Related]
19. Nrf2: friend and foe in preventing cigarette smoking-dependent lung disease.
Müller T; Hengstermann A
Chem Res Toxicol; 2012 Sep; 25(9):1805-24. PubMed ID: 22686525
[TBL] [Abstract][Full Text] [Related]
20. Activation of Nrf2 in defense against cadmium-induced oxidative stress.
He X; Chen MG; Ma Q
Chem Res Toxicol; 2008 Jul; 21(7):1375-83. PubMed ID: 18512965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]